-+ 0.00%
-+ 0.00%
-+ 0.00%

ACTUATE THERAPEUTICS - PATENT EXPECTED TO STRENGTHEN IP PORTFOLIO AND SUPPORT FUTURE COMMERCIALIZATION OF ORAL ELRAGLUSIB

Reuters·11/02/2026 13:02:53

Please log in to view news